Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Generated: March 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020647

« Back to Dashboard

NDA 020647 describes ELDEPRYL, which is a drug marketed by Somerset and is included in one NDA. It is available from one supplier. Additional details are available on the ELDEPRYL profile page.

The generic ingredient in ELDEPRYL is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for 020647
Ingredient:selegiline hydrochloride
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020647
Suppliers and Packaging for NDA: 020647
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647 NDA Mylan Specialty L.P. 49502-420 N 49502-420-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 15, 1996TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Fish and Richardson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.